Prostate Cancer

Research directly challenges a previous study which found that omega-3s increase the risk of prostate cancer

Omega-3 may help fight prostate cancer

By Niamh Michail

Omega-3 fatty acids inhibit the growth and spread of prostate cancer cells, say scientists – challenging a 2013 study which claimed omega-3s increase the risk of prostate cancer by 71%.

Is the omega-3 sector in decline?

Is the omega-3 sector in decline?

By Stephen DANIELLS

Growth in fish oil sales have been described by the CEO of Vitamin Shoppe as ‘softening’, while data from GOED indicates that 12 million users have left the category in the US, so is the omega-3 sector in decline?

CRN on silencing the critics with a dose of research

Guest Article

CRN on silencing the critics with a dose of research

By Steve Mister, President & CEO, Council for Responsible Nutrition

These are confusing times to be a dietary supplement consumer – one day, a particular nutrient is touted as a magic bullet, and the next it’s a waste of money. In this constant news cycle we live in, consumers are left even more puzzled about what’s really...

A Whale of a Fish Story for Omega-3s

Guest Commentary

A Whale of a Fish Story for Omega-3s

By Steve Mister

There’s something fishy going on with omega-3s these days, and it appears that some of the consumer media who reported on the study fell for it – hook, line and sinker. Of course I’m talking about the study that recently published in the Journal of the...

Not just industry slamming omega-3-prostate cancer links

Not just industry slamming omega-3-prostate cancer links

By Alan Ruth, PhD

Reaction to last week’s study linking omega-3 with prostate cancer have been vociferous and near-unanimous in condemning its methods and conclusions. Here Alan Ruth, PhD, and CEO of the Irish Health Trade Association (IHTA), explains why that condemnation...

Selenium qualified cancer claims: FDA approved (with disclaimer)

Selenium qualified health claims are usable, says attorney

By Shane Starling

The legal counsel who represented Durk Pearson, Sandy Shaw and others in the recent case that forced the Food and Drug Administration (FDA) to alter three approved selenium health claims, says his clients and others will use the claims.

Spotlight

Follow us

Products

View more

Webinars

Featured Suppliers

All